ANALOGIFREMGANGSMAATE VED FREMSTILLING AV TERAPEUTISK AKTIVE PYRIDO-PYRIMIDIN-DERIVATER

1454312 4 - Oxo - 6,7,8,9 - tetrahydropyrido[1,2-a]pyrimidines CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT 1 April 1974 [30 March 1973] 12908/74 Heading C2C Novel compounds I and their acid addition and quaternary ammonium salts in which R 1 is hydrogen or C 1-4 alkyl, R 2 is hydrogen halogen,...

Full description

Saved in:
Bibliographic Details
Main Authors KNOLL, JOZSEF, VASVARI, LELLE, HORVATH, AGNES, HERMECZ, ISTVAN, MESZAROS, ZOLTAN
Format Patent
LanguageNorwegian
Published 13.08.1979
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 1454312 4 - Oxo - 6,7,8,9 - tetrahydropyrido[1,2-a]pyrimidines CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT 1 April 1974 [30 March 1973] 12908/74 Heading C2C Novel compounds I and their acid addition and quaternary ammonium salts in which R 1 is hydrogen or C 1-4 alkyl, R 2 is hydrogen halogen, C 1-4 alkyl, C 7-9 aralkyl, amino, C 1-7 alkylamino, C 1-6 -alkanoylamino, hydroxy, C 1-4 alkoxy or carboxy or a derivative thereof, R 3 is hydrogen or carboxy or a derivative thereof and n is 1 or 2 are prepared by reducing a compound II in which R 4 is nitro on the group R 2 and R 5 is carboxy or a derivative thereof and if desired converting the compound formed to a compound I (R 3 =H) by decarboxylation or into a salt. Reduction of a compound II (R 4 =NO 2 ) leads to compounds I (R 2 =NH 2 ) or if carried out in the presence of a ketone solvent to compounds I (R 2 =C 3-7 alkylamino). Derivitives of the carboxyl group are prepared by esterification or amidation of the acid or acid chloride, or by reaction of an alkoxycarbonyl derivative with hydrazine or hydroxylamine. Compounds I prepared are those in which (a) R 1 is H, R 2 is CH 3 , n is 1 and R 3 is H, COOH, COOMe, COOEt CO-NH.NH 2 , CO-NH-CH 2 CH 2 Ph or CO-NHCH 2 CH 2 Ph(3,4diOMe) or (b) R 1 and R 2 are H, n is 1 and R 3 is COOMe or COOEt. The quaternary ammonium salt prepared is the methosulphate. Compounds I have analgesic, anti-inflammatory and anti-pyretic activity and form with a carrier or diluent a pharmaceutical composition which may be administered orally.
AbstractList 1454312 4 - Oxo - 6,7,8,9 - tetrahydropyrido[1,2-a]pyrimidines CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT 1 April 1974 [30 March 1973] 12908/74 Heading C2C Novel compounds I and their acid addition and quaternary ammonium salts in which R 1 is hydrogen or C 1-4 alkyl, R 2 is hydrogen halogen, C 1-4 alkyl, C 7-9 aralkyl, amino, C 1-7 alkylamino, C 1-6 -alkanoylamino, hydroxy, C 1-4 alkoxy or carboxy or a derivative thereof, R 3 is hydrogen or carboxy or a derivative thereof and n is 1 or 2 are prepared by reducing a compound II in which R 4 is nitro on the group R 2 and R 5 is carboxy or a derivative thereof and if desired converting the compound formed to a compound I (R 3 =H) by decarboxylation or into a salt. Reduction of a compound II (R 4 =NO 2 ) leads to compounds I (R 2 =NH 2 ) or if carried out in the presence of a ketone solvent to compounds I (R 2 =C 3-7 alkylamino). Derivitives of the carboxyl group are prepared by esterification or amidation of the acid or acid chloride, or by reaction of an alkoxycarbonyl derivative with hydrazine or hydroxylamine. Compounds I prepared are those in which (a) R 1 is H, R 2 is CH 3 , n is 1 and R 3 is H, COOH, COOMe, COOEt CO-NH.NH 2 , CO-NH-CH 2 CH 2 Ph or CO-NHCH 2 CH 2 Ph(3,4diOMe) or (b) R 1 and R 2 are H, n is 1 and R 3 is COOMe or COOEt. The quaternary ammonium salt prepared is the methosulphate. Compounds I have analgesic, anti-inflammatory and anti-pyretic activity and form with a carrier or diluent a pharmaceutical composition which may be administered orally.
Author HERMECZ, ISTVAN
HORVATH, AGNES
KNOLL, JOZSEF
VASVARI, LELLE
MESZAROS, ZOLTAN
Author_xml – fullname: KNOLL, JOZSEF
– fullname: VASVARI, LELLE
– fullname: HORVATH, AGNES
– fullname: HERMECZ, ISTVAN
– fullname: MESZAROS, ZOLTAN
BookMark eNqFjLsKwjAUQDPo4OsbzA8ErDq43prbeGmaliRGnEqROElaqP-PFtydDhwOZ8lmqU9xwW5gQNeKCouVAqNcBeCRB5R8Us6T1mQUh8A9Wmjw6smVHEpPAXlztyRrMaEiSUZItBS-A7tm82f3GuPmxxXbFujPFxGHvo3j0D1iiu_W1Nlxd9pneX74X3wAjB8yug
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID NO140821BB
GroupedDBID EVB
ID FETCH-epo_espacenet_NO140821BB3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:57:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Norwegian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_NO140821BB3
Notes Application Number: NO19740001125
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19790813&DB=EPODOC&CC=NO&NR=140821B
ParticipantIDs epo_espacenet_NO140821BB
PublicationCentury 1900
PublicationDate 19790813
PublicationDateYYYYMMDD 1979-08-13
PublicationDate_xml – month: 08
  year: 1979
  text: 19790813
  day: 13
PublicationDecade 1970
PublicationYear 1979
RelatedCompanies CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT
RelatedCompanies_xml – name: CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT
Score 2.3514416
Snippet 1454312 4 - Oxo - 6,7,8,9 - tetrahydropyrido[1,2-a]pyrimidines CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT 1 April 1974 [30 March 1973] 12908/74 Heading...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ANALOGIFREMGANGSMAATE VED FREMSTILLING AV TERAPEUTISK AKTIVE PYRIDO-PYRIMIDIN-DERIVATER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19790813&DB=EPODOC&locale=&CC=NO&NR=140821B
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFH9BNOpNUYPfO5jdFmFlfBwW060dTLNuGWPiiTA2iJdBZMZ_39cJ6oVTmzZ5aV_6-vu9tq8P4EHvZkiDSUNDbE3RQTEMDXGGaPOsZBy6kekydtgT7cGo9Tw2xhVYbGNhyn9Cv8rPEdGiZmjvRblfr_4OsVj5tnL9mLxj0_LJiUympj_hYp0eIhxRmWXywGe-rdq2KXxVhGZTJlZuWnuwjxy6I02Bx5YMSVn9xxPnBA4CFJUXp1DJlzU4srdp12pw6G1uu7G6Mbz1GbxSQWXaAifkXp-K_tCjNOJKzJkim4aRdMpFX6GxgvyUBnwUucMXBRmcG3MleAtd5muy8FzmCo2h-xajgPAc7h0e2QMNRzj51cVE-JuZWOQCqvkyz-qg9HCpz1tpu9FNkPCTbNqd6gnCTMfotVMy0y-hvkvK1e6uaziWGpUHqE1yA9Xi4zO7RQQukrtSe99004ND
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFH9BNOJNUYOf7GB2W4SV8XFYzLZ2MHHdMsaEE2FsGC-DyIz_vq8T1AunNm3y0r709fd7bV8fwIPaTZEGk4aC2Jqgg6JpCuIMUZZpwThULVVF7LDL24Nx63miTUrwtouFKf4J_So-R0SLWqC958V-vf47xKLF28rNY_yOTasnO9SpnPyEi3V6iHBEpqbOfI96lmxZOvdkHuhNkVi5aR7AIfLrjjAFFpkiJGX9H0_sUzjyUVSWn0EpW1WhYu3SrlXh2N3edmN1a3ibc3g1uCHSFtgBc_sG749cwwiZFDEqiaZRKJxy3peMSEJ-avhsHDqjoYQMzomY5E8Dh3qKKFyHOlyh6L5FKCC4gLrNQmug4Ahnv7qYcW87E5NcQjlbZWkNpB4u9WUraTe6MRJ-ks67czVGmOlovXZCFuoV1PZJud7fVYfKIHRfZjj84Q2cCO2Kw9QmuYVy_vGZ3iEa5_F9oclvyAWGNg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANALOGIFREMGANGSMAATE+VED+FREMSTILLING+AV+TERAPEUTISK+AKTIVE+PYRIDO-PYRIMIDIN-DERIVATER&rft.inventor=KNOLL%2C+JOZSEF&rft.inventor=VASVARI%2C+LELLE&rft.inventor=HORVATH%2C+AGNES&rft.inventor=HERMECZ%2C+ISTVAN&rft.inventor=MESZAROS%2C+ZOLTAN&rft.date=1979-08-13&rft.externalDBID=B&rft.externalDocID=NO140821BB